This article explores the emergence of subjectivity in ICH Q9 (R1).
Amin Ziaie
Advertisement
Amin Ziaie, QRM Merck & Co., Inc, PRST, the Technological University Dublin.
Articles by Amin Ziaie
Advertisement
Latest Updated Articles
Shining a Light on the Long Shadow of Subjectivity in Quality Risk ManagementPublished: March 3rd 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
BBB-Crossing Tech for Lysosomal Storage Disorders at Center of Chiesi–Aliada Partnership
2
UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report
3
Share Your Perspective on the Commissioner’s National Priority Vouchers Program
4
Achieving a Personalized Digital Control Arm for Preclinical Drug Evaluation
5
